Use of artificial intelligence in obstetric and gynaecological diagnostics: a protocol for a systematic review and meta-analysis

Anjalee Chaurasia,Georgia Curry,Yi Zhao,Fatema Dawoodbhoy,Jennifer Green,Matilde Vaninetti,Nishel Shah,Orene Greer
DOI: https://doi.org/10.1136/bmjopen-2023-082287
IF: 3.006
2024-05-09
BMJ Open
Abstract:Introduction Emerging developments in applications of artificial intelligence (AI) in healthcare offer the opportunity to improve diagnostic capabilities in obstetrics and gynaecology (O&G), ensuring early detection of pathology, optimal management and improving survival. Consensus on a robust AI healthcare framework is crucial for standardising protocols that promote data privacy and transparency, minimise bias, and ensure patient safety. Here, we describe the study protocol for a systematic review and meta-analysis to evaluate current applications of AI in O&G diagnostics with consideration of reporting standards used and their ethical implications. This protocol is written following the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P) 2015 checklist. Methods and analysis The study objective is to explore the current application of AI in O&G diagnostics and assess the reporting standards used in these studies. Electronic bibliographic databases MEDLINE, EMBASE and Cochrane will be searched. Study selection, data extraction and subsequent narrative synthesis and meta-analyses will be carried out following the PRISMA-P guidelines. Included papers will be English-language full-text articles from May 2015 to March 2024, which provide original data, as AI has been redefined in recent literature. Papers must use AI as the predictive method, focusing on improving O&G diagnostic outcomes. We will evaluate the reporting standards including the risk of bias, lack of transparency and consider the ethical implications and potential harm to patients. Outcome measures will involve assessing the included studies against gold-standard criteria for robustness of model development (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis, model predictive performance, model risk of bias and applicability (Prediction model Risk Of Bias Assessment Tool and study reporting (Consolidated Standards of Reporting Trials-AI) guidance. Ethics and dissemination Ethical approval is not required for this systematic review. Findings will be shared through peer-reviewed publications.There will be no patient or public involvement in this study. PROSPERO registration number CRD42022357024.
medicine, general & internal
What problem does this paper attempt to address?
The main objective of this paper is to evaluate the current state of applications of Artificial Intelligence (AI) in obstetric and gynecologic diagnostics through a systematic review and meta-analysis, and to examine the reporting standards used in these studies as well as their ethical implications. Specifically, the researchers aim to: 1. **Evaluate the current application of AI in obstetric and gynecologic diagnostics**: Understand how AI technology is being used to improve the diagnostic accuracy of obstetric and gynecologic diseases. 2. **Examine reporting standards**: Assess whether the studies adhere to recommended reporting standards, such as transparency, risk of bias, etc. 3. **Consider ethical implications**: Explore the potential ethical issues and risks to patients that may arise from the application of AI in the medical field. Through these evaluations, the research team hopes to identify areas that need improvement to enhance the reliability and safety of AI in obstetric and gynecologic diagnostics.